With a stabilization period in place for the Drug Supply Chain Security Act (DSCSA), industry leaders continue to work tirelessly to make sure systems are operating as needed to exchange billions of serial numbers in a secure, electronic, and interoperable manner, but the reality is that the industry is still short of the critical mass needed for exchanging this serialized data. In this session, a panel of experts will highlight some dramatic statistics, their impact on ensuring the continued movement of pharmaceutical products in the supply chain, and how you can be an ambassador in helping reach critical mass.